Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Jersey City, New Jersey
- Most recent report
- S-1, filed Sep 25, 2026
- Incorporated
- Delaware
- Filings on record
- 5 filings
- On EDGAR
- CIK 2084031
- Fiscal year ends
- December
Prospectuses and Registrations 1
Other 4
- DRS/A Draft registration statement, submitted confidentially, amended Jun 16, 2026
- DRS/A Draft registration statement, submitted confidentially, amended May 14, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Jan 30, 2026
- DRS Draft registration statement, submitted confidentially Oct 20, 2025
Everything here comes from Regenlab USA Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.